Could aducanumab be the first drug to slow Alzheimer’s disease?
The biotechnology company Biogen along with Japanese pharmaceutical company applied for a Biologics License Application with the U.S. Food and
Read MoreThe biotechnology company Biogen along with Japanese pharmaceutical company applied for a Biologics License Application with the U.S. Food and
Read MoreEffective medication to treat Alzheimer’s has proven elusive and it’s been more than a decade since any new drug received
Read More(By Richard Harris for NPR) Scientists say they’ve identified an enzyme that could help explain how exercise can slow or even
Read More(By Jon Hamilton for NPR) The same process that causes dew drops to form on a blade of grass appears
Read MoreOne in three seniors dies from Alzheimer’s disease or another dementia according to the Alzheimer’s Association. Although every person with
Read More(By Jon Hamilton for NPR) Three research institutions in Seattle have joined forces to study how Alzheimer’s disease takes root in
Read MoreAccording to a recent study led by Cedars-Sinai, it found Alzheimer’s disease in its early stages affects the integrity of
Read MoreA study funded by National Institute on Aging found people with dementia experience significantly higher costs of care compared to
Read MoreA team of Mayo Clinic neurologists have identified what appears to be unrecognized, early onset variant of Alzheimer’s disease. Known
Read MoreIn a recent paper published in the journal Annals of Neurology, it is reporting encouraging results from a small Phase
Read More